Philips had previously responded to ProPublica and the Pittsburgh Post-Gazette in the US, and NRC in the Netherlands. The articles do not present new facts and we do not agree with the characterizations made in these articles.
Philips’ priority is patient safety and quality. We understand how important Philips Respironics’ sleep therapy devices and ventilators are to patients that use them. Philips regrets any distress and concern for patients, their families and care providers in this matter, and deeply apologizes for this. Philips acted to protect patient safety by initiating and executing a voluntary recall notification/field safety notice of significant scale. We continue to dedicate all available resources to ensure that patients receive remediated devices.
The remediation of the sleep therapy devices is nearing completion, while the remediation of the affected ventilators is ongoing. Everyone at Philips is committed to achieving and maintaining the highest standards, building on a culture of integrity and compliance.
If you are a patient, business customer or clinician, you can find more information here.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 71,500 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Philips Global Press Office
Get our press releases by e-mail
You are about to visit a Philips global content page
Continue